Katie Kosko

DocwireNews

Children with SCD have significantly higher heme-oxygenase-1 (HO-1) levels compared with adults, according to recent data from the SickleGenAfrica Network project. Researchers believe this is the first study to show these findings.More than 2,000 children and adults are enrolled in the SickleGenAfrica Network. Participants joined between 2018 and 2021 and are from three sites in Ghana. All participants gave consent of samples in future studies.In this study, which was presented during the 65th ASH Annual Meeting &amp; Exposition, the researchers evaluated HO-1 levels using the enzyme-linked immunosorbent assay in 1,971 patients. More than half (55%) were female, with a median age of 13 years. Nine age groups were represented from 0 to older than 40 years. Participants were grouped by age using five-year intervals.Most patients had hemoglobin SS (58%), followed by sickle-hemoglobin C disease (30%), sickle-hereditary persistence of fetal hemoglobin (9%), and hemoglobin&ndash;S-beta + (3%).The researchers determined that children had elevated HO-1 levels versus older participants, and there was a three-fold drop-off in median HO-1 levels during adolescence (11-15 years old [73.9 ng/ml] and 16-20 years old [25.1 ng/ml]). Compared with females, males had higher average HO-1 levels (63.1 ng/ml vs 85.5 ng/ml, respectively).The pairwise Wilcoxon test, with Bonferroni correction for multiple comparisons, was used to examine and compare the median HO-1 level across the different age groups.&ldquo;To the best of our knowledge, this is the first study of HO-1 levels in patients with SCD at different ages,&rdquo; the researchers said. &ldquo;HO-1 may serve as a protective SCD factor, contributing to enhanced [acute chest syndrome (ACS)] survival rates in children versus adults.&rdquo;This study is just the beginning for the researchers, who hope to determine if baseline blood HO-1 levels can predict ACS incidence and severity. Furthermore, they aim to investigate genetic and epigenetic mechanisms controlling HO-1 expression.Reference Sowa A, Kudzi W, Paintsil V, et al. Enhanced expression of heme oxygenase-1 (HO-1) among children with sickle cell disease: results of the Sickle Cell Disease Genomics of Africa (SickleGenAfrica) study. Abstract #150. Presented at the 65th American Society of Hematology Annual Meeting &amp; Exposition; December 9-12; San Diego, California.

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

HO-1 Levels Elevated in Children Versus Adults with Sickle Cell Disease

Sickle Cell Disease

Pediatric patients with sickle cell disease (SCD) had significantly higher heme-oxygenase-1 levels compared with adults with SCD.

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe